| Symbol |
Name |
|
ADAM17
|
ADAM metallopeptidase domain 17
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGO2
|
argonaute RISC catalytic component 2
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALOX5
|
arachidonate 5-lipoxygenase
|
|
APLP2
|
amyloid beta (A4) precursor-like protein 2
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
ATF1
|
activating transcription factor 1
|
|
ATF2
|
activating transcription factor 2
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
CAMK1
|
calcium/calmodulin-dependent protein kinase I
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CDC25B
|
cell division cycle 25B
|
|
CDC37
|
cell division cycle 37
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CRYAB
|
crystallin, alpha B
|
|
EEF2
|
eukaryotic translation elongation factor 2
|
|
EEF2K
|
eukaryotic elongation factor 2 kinase
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
|
EIF4G1
|
eukaryotic translation initiation factor 4 gamma, 1
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FOXO1
|
forkhead box O1
|
|
GRIA1
|
glutamate receptor, ionotropic, AMPA 1
|
|
GRIA2
|
glutamate receptor, ionotropic, AMPA 2
|
|
H3F3B
|
H3 histone, family 3B (H3.3B)
|
|
HBEGF
|
heparin-binding EGF-like growth factor
|
|
HIST1H3A
|
histone cluster 1, H3a
|
|
HMGN1
|
high mobility group nucleosome binding domain 1
|
|
IRS1
|
insulin receptor substrate 1
|
|
IRS2
|
insulin receptor substrate 2
|
|
JDP2
|
Jun dimerization protein 2
|
|
JUN
|
jun proto-oncogene
|
|
KCNJ3
|
potassium channel, inwardly rectifying subfamily J, member 3
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KRT8
|
keratin 8, type II
|
|
MAP2K4
|
mitogen-activated protein kinase kinase 4
|
|
MAP3K1
|
mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK15
|
mitogen-activated protein kinase 15
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPK9
|
mitogen-activated protein kinase 9
|
|
MAPT
|
microtubule-associated protein tau
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MKNK1
|
MAP kinase interacting serine/threonine kinase 1
|
|
MKNK2
|
MAP kinase interacting serine/threonine kinase 2
|
|
MOK
|
MOK protein kinase
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
|
NR4A1
|
nuclear receptor subfamily 4, group A, member 1
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
PIAS2
|
protein inhibitor of activated STAT, 2
|
|
PLA2G4A
|
phospholipase A2, group IVA (cytosolic, calcium-dependent)
|
|
RARA
|
retinoic acid receptor, alpha
|
|
RBM17
|
RNA binding motif protein 17
|
|
RCSD1
|
RCSD domain containing 1
|
|
RPS6KA4
|
ribosomal protein S6 kinase, 90kDa, polypeptide 4
|
|
RPS6KA5
|
ribosomal protein S6 kinase, 90kDa, polypeptide 5
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RPTOR
|
regulatory associated protein of MTOR, complex 1
|
|
RTN4
|
reticulon 4
|
|
SCN10A
|
sodium channel, voltage gated, type X alpha subunit
|
|
SCN8A
|
sodium channel, voltage gated, type VIII alpha subunit
|
|
SRF
|
serum response factor (c-fos serum response element-binding transcription factor)
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
TAB1
|
TGF-beta activated kinase 1/MAP3K7 binding protein 1
|
|
TP53
|
tumor protein p53
|
|
TSC2
|
tuberous sclerosis 2
|
|
WWOX
|
WW domain containing oxidoreductase
|
